Skip to main content
Smart Investors Daily
Invesco Nasdaq Biotechnology ETF logo

NASDAQ · IBBQ

Invesco Nasdaq Biotechnology ETF

Financial Services · Asset Management

$34.11

Down-$0.45 (-1.32%)

Updated Nov 20, 2026, 8:01 PM

SID Score

4.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
41.2M
P/E ratio
—
Dividend yield
0.67%
52-week range
$27.46 – $37.01
Volume
22.48K
Avg. volume
20K

Price performance · IBBQ

IBBQ price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

IBBQ closed at $34.11 after 21 trading sessions, down 2.32% for the selected period.

Last close
$34.11
Period change
-2.32%
Period low
$34.11
Period high
$36.87
Daily close
View OHLC price history
IBBQ OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$34.69$34.74$34.09$34.1122.48K
Nov 18, 2026$34.51$34.90$34.42$34.4812.36K
Nov 17, 2026$34.97$34.97$34.35$34.6840.99K
Nov 16, 2026$35.68$35.68$34.88$34.9241.24K
Nov 13, 2026$35.82$35.82$35.36$35.6829.73K
Nov 12, 2026$36.59$36.59$35.81$35.8234.61K
Nov 11, 2026$36.47$36.71$36.345$36.6770.92K
Nov 10, 2026$36.81$36.81$36.19$36.4661.46K
Nov 9, 2026$36.23$37.0099$35.7918$36.85100.23K
Nov 6, 2026$35.10$36.0488$34.93$35.83235.3K
Nov 5, 2026$36.84$37.00$35.06$35.10241.6K
Nov 4, 2026$36.47$36.94$35.76$36.8750.63K
Nov 3, 2026$35.89$36.325$35.815$35.9742.1K
Nov 2, 2026$36.36$36.43$35.60$35.6034.4K
Oct 30, 2026$36.33$36.95$35.9968$36.1763.57K
Oct 29, 2026$36.14$36.57$35.83$36.171658.5K
Oct 28, 2026$35.19$35.94$35.00$35.8338.38K
Oct 27, 2026$34.61$35.38$34.57$35.3828.04K
Oct 26, 2026$34.55$34.83$34.50$34.683476.25K
Oct 23, 2026$34.57$34.75$34.286$34.5234.29K
Oct 22, 2026$35.36$35.4199$34.61$34.9237.73K

Latest IBBQ news

The latest Smart Investors Daily articles mentioning IBBQ.

IBBQ research

Overview

Company profile and research snapshot.

Company profile

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.